Skip to main content
Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
73.90
+0.95 (1.30%)
Aug 15, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.
Year Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Biopharmaceutical Research & Development and Commercialisation
464.18M
Log In
Log In
Log In
Biopharmaceutical Research & Development and Commercialisation Growth
18.63%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Overseas
424.09M
Log In
Log In
Log In
Overseas Growth
8.67%
Log In
Log In
Log In
China
40.09M
Log In
Log In
Log In
China Growth
3917.60%
Log In
Log In
Log In